Skip to content


Trulicity (dulaglutide) is a protein pharmaceutical. Dulaglutide was first approved as Trulicity on 2014-09-18. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus.
Trade Name Trulicity
Common Name Dulaglutide
Indication type 2 diabetes mellitus
Drug Class Peptides: GLP peptide analogs
Get full access now